Key indicators: single-crystal X-ray study; T = 120 K; mean (C-C) = 0.002 Å; R factor = 0.042; wR factor = 0.107; data-to-parameter ratio = 13.7.
In the title compound, C 16 H 23 ClN 2 O, both six-membered rings adopt chair conformations, thus allowing the formation of an intramolecular N-HÁ Á ÁN hydrogen bond. In the crystal, adjacent molecules are combined into chains running along the ac diagonal via O-HÁ Á ÁN hydrogen bonds.
Related literature
For general background to chemistry affording syn-3,7-diazabicyclo[3.3.1]nonan-9-ols, see: Vatsadze et al. (2006). 3,5,6,7-Tetrasubstituted 3,6-diazabicyclo[3.2.1] octanes, their biological activity as enzyme inhibitors and their X-ray structures have been reported by: Kudryavtsev (2010) ; Kudryavtsev & Churakov (2012) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (2010)).
The solution of 2.23 g (6.9 mmol) of anti-5-(4-chlorobenzyl)-3-formyl-1,5-dimethyl-3,7-diazabicyclo[3.3.1]nonan-9-ol (Vatsadze et al.(2006) ) in conc. HCl (molar ratio ca 1:120) was refluxed for 21 h. The cooled solution was neutralized with NaOH to the pH 9-10. The precipitate formed was filtered off, washed with water to neutral pH of mother liquor, then once with ether, recrystallized from H-8a, J 11.9); 3.21 (d, 2H, H-6 e, H-8 e, J 12.6); 3.24 (s, 1H, H-9); 3.43 (s, 2H, CH 2 Ar); 7.34-7.43 (m, 4H, H(Ar)). 
Refinement
All hydrogen atoms were located in a difference Fourier map and refined isotropically. 
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